Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
06:30a ROCHE : Information and promotion products
03:35a INSYS THERAPEUTICS : N.J. attorney general names Insys founder Kapoor as defendant in opioid false-claims lawsuit
02:04a CENTENE : The Sacramento Bee, City Beat column
01:53a ROCHE : First-ever breast cancer patient journey study in sub-Saharan Africa
01:14a CANNIMED TO ACQUIRE UP CANNABIS INC. (NEWSTRIKE RESOURCES LTD. - TSX-V : HIP) to Create a Premier Global Cannabis Company
12:56a THE LATEST : Nevada won't return execution drug to Pfizer
12:49a OTSUKA : FDA approves mental health pill with sensor to track use compliance
11/17 STERLING BIOTECH : SC to hear plea against Asthana's appointment today
11/17 BIODELIVERY SCIENCES INTERNATIONAL INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
11/17 DANDRIT BIOTECH USA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
11/17 ONCONOVA THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
11/17 AUDENTES THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
11/17 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
11/17 ADCARE HEALTH : Nijak named Koester administrator
11/17 ROBBINS ARROYO LLP : Meridian Bioscience, Inc. (VIVO) Misled Shareholders According to a Recently Filed Class Action
11/17 CATALYST BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
11/17 ACORDA THERAPEUTICS INC : ACORDA THERAPEUTICS Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Investing In Acorda Therapeutics, Inc. To Contact The Firm
11/17 BOSTON SCIENTIFIC CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
11/17 JOHNSON & JOHNSON : New Real-World Analysis Shows INVOKANA® (canagliflozin) and Other SGLT2 Inhibitors Reduced the Risk of Death and Cardiovascular Events Compared to Other Diabetes Medicines
11/17 IIROC Trade Halt - CanniMed Therapeutics Inc.
11/17 CANNIMED THERAPEUTICS : IIROC Trade Halt - CanniMed Therapeutics Inc.
11/17 XENETIC BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
11/17 CODEXIS INC : Change in Directors or Principal Officers (form 8-K)
11/17 SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
11/17 US NEUROSURGICAL : U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
11/17 GI DYNAMICS : to Provide Corporate Update and 2017 Third Quarter Results
11/17 AGIOS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)
11/17 HEAT BIOLOGICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
11/17 RIGEL PHARMACEUTICALS, INC. : Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
11/17 CARDIOVASCULAR SYSTEMS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
11/17 CERECOR INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
11/17 SAGE THERAPEUTICS : Announces Closing of $345 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares
11/17 PARATEK PHARMACEUTICALS : MMS Selected by Paratek to Support its NDA Submissions for Omadacycline
11/17 ROCHE : FDA Approves First Test for Screening Zika Virus in Blood Donations
11/17 ELI LILLY AND : Lilly to Participate in Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference
11/17 RESMED INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
11/17 WEISSLAW LLP : Investigates Almost Family, Inc. Acquisition
11/17 Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Acorda Therapeutics, Inc. – ACOR
11/17 INTERCEPT PHARMACEUTICALS INC : Levi & Korsinsky, LLP Reminds Shareholders of Intercept Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 27, 2017 - ICPT
11/17 DENTSPLY SIRONA : U.S. Patents Awarded to Inventors in Massachusetts (Nov. 17)
11/17 ELEVEN BIOTHERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
11/17 PFIZER : tells Nebraska not to use its drugs in execution
11/17 GNCA The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Genocea Biosciences, Inc. and a Lead Plaintiff Deadline of January 2, 2018
11/17 PFIZER : LETHAL INJECTION Pfizer demands that Nebraska return drugs if it has them
11/17 LUZ SAÚDE : Hospital da Luz Arrábida Oncologist Explains Pancreatic Cancer Symptoms
11/17 NOVN The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Novan, Inc. and a Lead Plaintiff Deadline of January 2, 2018
11/17 LUZ SAÚDE : Carlos Palos, HBA Specialist, Represents Portugal in Brussels
11/17 THE KLEIN LAW FIRM : Reminds Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017
11/17 TITAN MEDICAL : Announces Filing of Amended and Restated Preliminary Prospectus
11/17 CURASAN AG : Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
11/17 H LUNDBECK : Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
11/17 PFIZER : Neb. quiet on identity of drugs supplier
11/17 QUEST DIAGNOSTICS : Accesa Labs Partners with YMCA to Offer Easy and Affordable Blood Tests for Diabetes Awareness Month
11/17 ULTRAGENYX PHARMACEUTICAL : Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
11/17 LABORATORY OF AMERICA : Cority Enhances Clinical Testing Solution with LabCorp Interface
11/17 SWEDISH ORPHAN BIOVITRUM : First patient randomised in study evaluating safety and efficacy of anakinra in Stills disease
11/17 ACORDA THERAPEUTICS : reports sepsis-related deaths in late-stage Parkinsons drug trial
11/17 GLENMARK PHARMACEUTICALS : launches nicotine gum Kwitz
11/17 PFIZER : NICE approves Novartis and Pfizers rival breast cancer drugs
11/17 NAMASTE TECHNOLOGIES : Provides Corporate Update on Cannmart and MD
1  2  3  4  5  6  7  8  9  10Next
Advertisement